PLASMA CELL MYELOMA
Clinical trials for PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat multiple myeloma: first human trial of SAR442085
Disease control CompletedThis early-stage study tested a new drug called SAR442085 in 37 adults with multiple myeloma that had returned or stopped responding to prior treatments. The main goals were to find the safest dose and check for any signs that the drug shrinks tumors. Researchers also monitored s…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 29, 2026 04:30 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for people with high-risk blood cancers like leukemia and lymphoma. First, patients received low-dose chemotherapy and radiation to weaken their cancer and immune system. Then, they got donor stem cells and immune cells to help fi…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Apr 29, 2026 04:29 UTC